Second dose, 122 of 676 subjects in the experimental group (group 1) experienced fever as a side effect. After the second dos
e, 57 of 650 of the subjects in the control group (group 2) experienced fever as a side effect. Does the evidence suggest that a higher proportion of subjects in group 1 experienced fever as a side effect than subjects in group 2 at the alphaequals0.01 level of significance?
